Literature DB >> 2988421

The mechanisms of antiinflammatory steroid action in allergic diseases.

R P Schleimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2988421     DOI： 10.1146/annurev.pa.25.040185.002121

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  12 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

3.  Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.

Authors:  U Pipkorn; D Proud; L M Lichtenstein; R P Schleimer; S P Peters; N F Adkinson; A Kagey-Sobotka; P S Norman; R M Naclerio
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 4.  Mast cell polymorphisms. Present concepts, future directions.

Authors:  D Befus; H Fujimaki; T D Lee; M Swieter
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats.

Authors:  J R Avila; C A de la Lastra; M J Martin; V Motilva; I Luque; D Delgado; J Esteban; J Herrerias
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

6.  An anti-inflammatory steroid inhibits tissue sensitization by IgE in vivo.

Authors:  P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

Review 7.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

8.  Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.

Authors:  C Kohler; M Carroll; E Tarrant; L Torley; A Wissner
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

Review 9.  Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.

Authors:  H M Bryson; D Faulds
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 10.  Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

Authors:  F Shanahan; P Anton
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.